{"id":"W4235301199","doi":"10.1016/j.jval.2017.08.1389","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Medicine; Heart failure; Ejection fraction; Internal medicine; Population; Cardiology; Blood pressure; Angiotensin-converting enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006216665,0.0001565605,0.0003235259,0.0002814802,0.000242851,0.0005764071,0.0004139503,0.0002814053,0.002225982],"category_scores_gemma":[0.001024669,0.00008370115,0.0003485526,0.0003247171,0.0002126245,0.0002036249,0.0002691094,0.0007616059,0.00007555912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00130811,"about_ca_system_score_gemma":0.002362384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02568547,"about_ca_topic_score_gemma":0.04208563,"domain_scores_codex":[0.9997547,0.0001145515,0.00001788206,0.00002615418,0.00002201168,0.00006458865],"domain_scores_gemma":[0.9996,0.00007492607,0.0001550936,0.00001531217,0.00006003421,0.00009461007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02522345,0.004335684,0.5347876,0.002442532,0.001676447,0.001797594,0.0006120844,0.004038282,0.009977981,0.009758398,0.02698447,0.3783654],"study_design_scores_gemma":[0.005025431,0.004717886,0.9451877,0.000699094,0.002182956,0.0007724537,0.001286475,0.004387744,0.00213005,0.001893699,0.03165834,0.0000581356],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9597961,0.01534622,0.001114152,0.01663917,0.0002347262,0.00006519329,0.001599837,0.00006632581,0.005138373],"genre_scores_gemma":[0.9914169,0.004674852,0.001527119,0.0007928165,0.0002061999,0.00004996999,0.000628238,0.000008167044,0.0006957081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02568547,"threshold_uncertainty_score":0.05107188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06002917433916491,"score_gpt":0.3546279566412262,"score_spread":0.2945987823020613,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}